|
Top Stories | September 1, 2010 | Manjula Puthenedam
A series of studies published in the September issue of the Journal of Nuclear Medicine show that molecular imaging plays a critical role in the evaluation and treatment planning for a spectrum of cancers, including thyroid cancer, neuroendocrine tumors, Hodgkin lymphoma and non-small cell lung cancer.
Read more...
Contracts & Installations | August 31, 2010 | Manjula Puthenedam
Aspect Magnet Technologies has completed multiple installations of its deskside, compact M2 MRI systems for use in preclinical imaging.
Read more...
Industry News | August 31, 2010 | Manjula Puthenedam
The Canadian government has invested more than $911,000 to support medical and pharmaceutical research at Canada's National Laboratory for Particle and Nuclear Physics--TRIUMF--through the Western Diversification Program.
Read more...
Clinical Studies | August 30, 2010 | Manjula Puthenedam
PET/CT using [11C] choline may be useful to restage in patients with prostate cancer who had increasing prostate-specific antigen (PSA) after radical prostatectomy and no disease evidence on conventional imaging, according to a study published in the September issue of the Journal of Urology.
Read more...
Clinical Studies | August 29, 2010 | Manjula Puthenedam
The combination of FDG PET/CT and circulating tumor cell (CTC) counts might be a useful tool to monitor response to therapy in breast cancer patients, according to a study published in this month's Journal of Nuclear Medicine.
Read more...
Partnerships & Alliances | August 29, 2010 | Manjula Puthenedam
IBA (Ion Beam Applications) has entered into an agreement with Bayer Schering Pharma, Germany for chemical process development and clinical trial doses supply of Florbetaben, a PET tracer in development for the detection of beta-amyloid deposits in the brain, a hallmark of Alzheimer’s disease.
Read more...
Executive Announcements | August 29, 2010 | Manjula Puthenedam
Areva Med has formed an advisory committee comprised of five high-level scientists who will provide the firm with strategic advice and scientific guidance in the field of radio-immunotherapy using its lead-212 isotope.
Read more...
Top Stories | August 27, 2010 | Manjula Puthenedam
The repair of the High Flux Reactor (HFR) in Petten, the Netherlands, is proceeding well and the reactor is expected to achieve the first HFR Full Power Day (45 MW) on Sept. 9, according to the Nuclear Research and Consultancy Group of the Netherlands.
Read more...
|
Industry News | August 26, 2010 | Gina Narcisi
The U.S. Department of Energy (DoE) has granted Dynasil seven of its phase-II small business innovation research (SBIR) projects awards, totaling $6.2 million.
Read more...
Clinical Studies | August 25, 2010 | Gina Narcisi
Nuclear MR (NMR) spectroscopy, a new method of testing that can assess a tissue metabolic profile, offers a noninvasive technique for distinguishing between different neurological disorders in patients and may enable earlier diagnosis, according to a study published online in March in the Journal of Comparative Neurology.
Read more...
Industry News | August 25, 2010 | Manjula Puthenedam
The University of Maryland, based in College Park, Md. has received a $1.9 million grant from the National Science Foundation to acquire a superconducting 800 MHz Nuclear Magnetic Resonance (NMR) spectrometer to conduct investigations of biomolecular structure.
Read more...
Top Stories | August 25, 2010 | Manjula Puthenedam
The Atomic Energy of Canada Limited (AECL) has scheduled another extended outage for next spring, as part of the Chalk River Laboratories, National Research Universal (NRU) reactor's return to service activities.
Read more...
Clinical Studies | August 23, 2010 | Manjula Puthenedam
Whole-body FDG-PET scans revealed that visceral adipose tissue has increased glucose uptake compared with subcutaneous adipose tissue and the differences in stromal metabolic activity can aid in cardiovascular risk stratification, according to a study published in this month’s Journal of American College of Cardiology: Cardiovascular Imaging.
Read more...
Clinical Studies | August 23, 2010 | Manjula Puthenedam
A novel protein called sucrose nonfermenting AMPK-related kinase (SNARK) involved in mediating glucose transport has been found to be activated in skeletal muscle in response to contraction and exercise in both rodents and humans, according to a study published Aug. 16 in Proceedings of the National Academy of Sciences.
Read more...
Partnerships & Alliances | August 23, 2010 | Gina Narcisi
Medrad has listed the Intego PET Infusion system for molecular imaging with healthcare supply contracting company Novation.
Read more...
Clinical Studies | August 22, 2010 | Manjula Puthenedam
The addition of chemotherapy (cisplatin) to radiotherapy improves survival of women with locally advanced cervical cancer compared with radiotherapy alone, without an apparent rise in late treatment complications, according to a study published in the September issue of Clinical Oncology.
Read more...
|
RSS 
